US states plan drug purchasing pool

26 March 2001

Officials from six US states, led by West Virginia, are currentlydrawing up plans to establish a pharmaceutical purchasing pool. Their intention is, at least initially, to obtain rebates from prescription drug manufacturers for employees of the states, although the initiative could eventually also include Medicaid enrollees, Bill Case, a spokesman for West Virginia Governor Bob Wise, has told Reuters.

The other states represented at the meeting were Alabama, Georgia, North Carolina, South Carolina and Washington, and a further five or six states are expected to join the group's next meeting, which will be held in Atlanta, Georgia, in April.

Mr Case said the group has "been getting calls from states that weren't invited that want in," adding that Gov Wise's original proposal for a multi-state drug-buying initiative, made when he was running for office late last year, had been to include Medicaid within the purchasing group. While "we haven't given up on that," Mr Case told Reuters, for the sake of expediency, the initial plan will concentrate on state employees only.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight